The Collier Report of U.S. Government Contracting

Old School Reporting Using Modern Technology

Murty Pharmaceuticals Inc

  • Contact Person: Syam Murty
  • Contact Phone: 859-266-2446
  • Contact Email: smurty@mpirx.com
  • Business Structure:
  • Corporate Entity (Not Tax Exempt)
  • Business Type:
  • Minority Owned Business
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Manufacturer of Goods
  • Subcontinent Asian (Asian-Indian) American Owned
  • Subchapter S Corporation
  • Industries Served: Medicinal and Botanical Manufacturing, Pharmaceutical Preparation Manufacturing
  • Product Areas: DRUGS AND BIOLOGICALS, LIFE SCIENCES (BASIC), R&D- GENERAL SCIENCE/TECHNOLOGY: LIFE SCIENCES (BASIC RESEARCH)

Sampling of Federal Government Funding Actions/Set Asides

In order by amount of set aside monies.

  • $334,667 - Thursday the 20th of September 2012
    National Institutes Of Health
    NIH, NIDA, OD OM OA OFC ACQUISITIONS
    HHSN271201000010I-PREPARATION OF INTRAVENOUS FORMULATIONS OF (R,R)-4'-METHOXY-1- NAPHTHYLFENOTEROL (MNF)-MURTY PHARMACEUTICALS, INC.CAN 8469735

© Copyright 2019
The Collier Report
published by 1918 Media LLC.
Information displayed in this dossier has been provided through available open source or public sources. No reliance should be made by readers or Collier Report subscribers. Funding actions are complicated and do not always represent dollar-for-dollar payments to vendors nor do they represent payments in certain instances. Requests for the modification of displayed information may be made to help.desk@1918.media.